ClearPoint Neuro, Inc. Peo Total Comp Amt
ClearPoint Neuro, Inc. (CLPT) reported Peo Total Comp Amt of $2.81 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-10.
Financial Statements › Notes
ecd:PeoTotalCompAmt · last filed 2026-04-10
| Period end | Peo Total Comp Amt 12 month |
|---|---|
| 2025-12-31 | $2.81M DEF 14A · filed 2026-04-10 |
| 2024-12-31 | $2.53M DEF 14A · filed 2026-04-10 |
| 2023-12-31 | $2.00M DEF 14A · filed 2026-04-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |